Open Funding Opportunities:  Alzheimer’s Drug Discovery Foundation

The ADDF has updated our RFPs for 2018.
Visit the website to view next year’s deadlines, review the criteria for each RFP, and log in to the new ADDF Funding Portal.
Upcoming Letter of Intent Deadline: January 19, 2018

PROGRAM TO ACCELERATE CLINICAL TRIALS
This RFP supports Phase 0 through Phase 2 clinical trials, experimental medicine studies in human subjects, and IND-enabling studies.

BIOMARKERS DEVELOPMENT
This funds the development and validation of biomarkers to enhance clinical trials for Alzheimer’s disease, related dementias, and cognitive aging.

PREVENTION BEYOND THE PIPELINE
This RFP supports comparative effectiveness research, prevention clinical trials, and epidemiological studies on whether the use or choice of drugs alters the risk for cognitive decline.

DRUG DISCOVERY
This supports programs advancing lead molecules to clinical candidate selection, or building preclinical evidence in relevant animal models for repurposed/repositioned drugs.

MORE INFORMATION ON ALL RFPS

 

Add Your Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.